COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Christopher Leahy

Vice President & Chief Financial Officer

Chris Leahy heads the Global Finance function for Piramal Pharma Solutions across North America, Europe and India, including reporting, analysis and internal controls.

Chris has over 24 years of experience in various Finance roles including Audit, Financial Planning and Analysis, Financial Reporting, M&A, Taxation, Procurement, with a strong commercial focus. He is a qualified UK Chartered Accountant with over 17 years’ experience in the Pharmaceutical industry.

He has a BSC (Hons) in Mathematics from Bristol University (UK) and has been with Piramal Pharma Solutions for over 11 years, previously working for Price Waterhouse, ICI and Pfizer.

Leadership Team

Great!